Investing in CRISPR Therapeutics AG? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-CRSP-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-CRSP-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-CRSP-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how CRISPR Therapeutics AG ($CRSP) has been trading over the last 2 weeks and the past day especially. On its latest session, CRISPR Therapeutics AG ($CRSP) opened at 50.0, reaching a high of 52.09 and a low of 49.76 before closing at a price of 51.92. There was a total volume of 1463063.
VOLUME INDICATORS: We saw an accumulation-distribution index of 167.88052, an on-balance volume of -49.66, chaikin money flow of 1.22967 and a force index of 3.3916. There was an ease of movement rating of 0.02645, a volume-price trend of 12.43154 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.13792, bolinger bands of 50.78392, an upper bollinger band of 47.61608, lower bollinger band of 49.76, a bollinger high band indicator of nan, bollinger low band indicator of 1.0, a central keltner channel of 50.61667, high band keltner channel of 48.52667, low band keltner channel of 52.70667, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 49.76, a donchian channel low band of 49.76, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.02513, a MACD signal of -0.01396, a MACD difference of -0.01117, a fast Exponential Moving Average (EMA) indicator of 49.76, a slow Exponential Moving Average (EMA) indicator of 49.76, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.20441, a trix of 16.56545, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of -66.66667, a Detrended Price Oscillator (DPO) of -9.59813, a KST Oscillator (KST) of 238.98607 and a KST Oscillator (KST Signal) of 238.98607 (leaving a KST difference of -6.97179). We also found an Ichimoku rating of 51.045, an Ichimoku B rating of 51.045, a Ichimoku visual trend A of 42.55078, an Ichimoku visual trend B of 44.14754, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 97.56051, a stochastic oscillator of 111.48325, a stochastic oscillator signal of 111.48325, a Williams %R rating of 11.48325 and an awesome oscillator of -0.22658.
RETURNS: There was a daily return of 23.89861, a daily log return of -2.27652 and a cumulative return of -2.2508.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for CRISPR Therapeutics AG ($CRSP)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on CRISPR Therapeutics AG, we strongly advise CRISPR Therapeutics AG investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like CRISPR Therapeutics AG – without this you are trading blind:
We will of course continue to cover the news and price action of CRISPR Therapeutics AG, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling CRISPR Therapeutics AG ($CRSP) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.